DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20211339

Hemodialysis duration and underweight as a risk factors of renal osteodystrophy (chronic kidney disease - mineral bone disorder) on regular hemodialysis patient

Gde Dedy Andika, I. Ketut Siki Kawiyana, I. Gede Eka Wiratnaya, Yenny Kandarini

Abstract


Background: Chronic kidney disease (CKD) is related to systemic disorders affecting multiple organs, including the bone, known as osteoporosis or renal osteodystrophy. Long duration of hemodialysis and underweight based on the Body Mass Index (BMI) is thought to be risk factors for renal osteodystrophy. This study aims to determine the risk factors in the form of hemodialysis duration and underweight in the incidence of renal osteodystrophy in patients with CKD stage 5.

Methods: This research is an analytic observational study with case and control group involving 26 patients. In each group, anamnesis, anthropometric examination and bone mass density (BMD) examination with DEXA were performed. Analysis using Chi-squared test, and an odds ratio (OR) calculation were performed to determine the effect of hemodialysis duration and underweight as risk factors for renal osteodystrophy in CKD patients

Results: There is a significant difference in the duration of hemodialysis (p=0.047, 95% CI=0.97-29.39) and underweight (p=0.011, 95% CI=1.39-141.49) between the CKD patient group. In addition, it was also found that the duration of HD (OR=5.33) and underweight (OR=14) were significant risk factors for renal osteodystrophy in CKD patients.

Conclusions: There is significant differences in the duration of hemodialysis and underweight between CKD patients with renal osteodystrophy and without renal osteodystrophy. Hemodialysis duration and underweight are also a significant risk factors for renal osteodystrophy in patients with CKD.


Keywords


Hemodialysis, Underweight, Renal osteodystrophy, Chronic kidney disease, Mineral bone disorder

Full Text:

PDF

References


Naylor KL, McArthur E, Leslie WD, Fraser LA, Jamal SA, Cadarette SM, et al. The three-year incidence of fracture in chronic kidney disease. Kidney Int. 2014; 86(4):810-8.

Drüeke TB, Massy ZA. Changing bone patterns with progression of chronic kidney disease. Kidney International. 2016;89(2):289-302.

Hsu, Chia-Yu; Chen, Li-Ru; Chen K-H. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review. Int J Mol Sci. 2020;21(18): 6846.

Lorente-Ramos R, Azpeitia-Armán J, Muñoz-Hernández A, García-Gómez JM, Díez-Martínez P, Grande-Bárez M. Dual-energy x-ray absorptiometry in the diagnosis of osteoporosis: A practical guide. American Journal of Roentgenology. 2011;196(4):897-904.

El-Kishawi AMW, El-Nahas AM. Renal osteodystrophy: review of the disease and its treatment. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2020;17(3):373-82.

Elder G. Pathophysiology and recent advances in the management of renal osteodystrophy. Journal of Bone and Mineral Research. 2002;17(12):2094-105.

Fusaro M, Gallieni M, Jamal SA. Fractures in chronic kidney disease: Neglected, common, and associated with sickness and death. Kidney International. 2014;1:20-22.

World Health Organization. Who Scientific Group on the Assessment of Osteoporosis At Primary Health. In: World HealthSummary Meeting Report Brussels, Belgium, 2004. 2007. https://www.who.int/chp/topics/Osteoporosis.pdf. Last accessed on 10th November, 2020.

Li C, Chen X, Li Y, Zhou Y, Yan J, Du X. Factors and Outcome of Renal Osteodystrophy-Associated Initial Fragility Fracture in End-Stage Renal Disease Patients. Kidney Dis. 2019;5:118-25.

Brunerová L, Ronová P, Verešová J, Beranová P, Potoèková J, Kasalický P, et al. Osteoporosis and Impaired Trabecular Bone Score in Hemodialysis Patients. Kidney Blood Press Res. 2016.

Tariq, M; Sulaiman S. Prevalence of Osteopenia and Osteoporosis among Chronic Kidney Disease Patients: A Systematic Review. Open Urol Nephrol J. 2007;18(3):875-85.

Polymeris A, Doumouchtsis K, Grapsa E. Bone mineral density and bone metabolism in hemodialysis patients. Correlation with PTH, 25OHD3 and leptin. Nefrologia. 2012.

Balouche A. Renal Osteodystrophy in End Stage Renal Disease Patients in a Center in South East of Iran: A Cross- Sectional Study. Int J Clin Ski. 2017.

Hegazy IS, el Raghy HA, Abdel-Aziz SB, Elhabashi EM. Study of the effect of dietary counselling on the improvement of end-stage renal disease patients. East Mediterr Heal J. 2013.

Montalcini T, Romeo S, Ferro Y, Migliaccio V, Gazzaruso C, Pujia A. Osteoporosis in chronic inflammatory disease: The role of malnutrition. Endocrine. 2013.

Karavetian M, Elzein H, Rizk R, Jibai R, de Vries N. Nutritional education for management of osteodystrophy: Impact on serum phosphorus, quality of life, and malnutrition. Hemodial Int. 2016.